Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855422 · ClinicalTrials.gov registry record
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
A clinical trial of Transplant; Complication, Rejection, sponsored by Montefiore Medical Center.
- Active
- Registry status
- 42
- Enrollment target
- 1
- Study location
NCT04855422 is a study of Transplant; Complication, Rejection that is active but no longer recruiting, run by Montefiore Medical Center. The registered enrollment target is 42 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04855422, a study of Transplant; Complication, Rejection, is active but no longer recruiting, sponsored by Montefiore Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-randomized, non-interventional, prospective pilot cohort study to monitor SPK patients post-transplant to determine if non-invasive measures using dd-cfDNA (Allosure) and AlloMap can assess an array of immune panels to predict and confirm the development of allograft injury and rejection in either organ. Aims of the study 1. To develop and validate AlloSure and AlloMap in SPK transplant recipients with stable allograft function and in diagnosis of acute TCMR and ABMR in either organ 2. To assess the ability of AlloSure and AlloMap to determine early discordant rejection in SPK recipients 3. To investigate AlloSure and AlloMap in SPK transplant recipients with diagnosis of BKV viremia
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Allosure
- DIAGNOSTIC_TEST AlloMap
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04855422
The ClinicalTrials.gov registry entry for NCT04855422 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transplant; Complication, Rejection appearing as the primary indexed condition, and to 2 interventions - of which Allosure is the first listed.
NCT04855422 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04855422 about?
NCT04855422 is a clinical study titled "Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.". This is a non-randomized, non-interventional, prospective pilot cohort study to monitor SPK patients post-transplant to determine if non-invasive measures using dd-cfDNA (Allosure) and AlloMap can assess an array of immune panels to predict and confirm the development of allograft injury and rejecti...
What is the current status of trial NCT04855422?
This trial is currently active not recruiting. The enrollment target is 42 participants. The study started on 2021-07-14. Estimated completion is 2026-06.
What conditions does trial NCT04855422 study?
This clinical trial studies the following conditions: Transplant; Complication, Rejection.
What interventions are being tested in trial NCT04855422?
The interventions under investigation include: Allosure (DIAGNOSTIC_TEST), AlloMap (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04855422?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04855422 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.